Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RPS6KA2 | Q15349 | 1/20 | 0.36 |
| ▸ | FABP1 | P07148 | 5/20 | 0.35 |
| ▸ | KDR | P35968 | 1/20 | 0.35 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.35 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.34 |
| ▸ | MCL1 | Q07820 | 4/20 | 0.34 |
| ▸ | BCL2L1 | Q07817 | 3/20 | 0.34 |
| ▸ | AHR | P35869 | 1/20 | 0.34 |
| ▸ | ATR | Q13535 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18780342 | 0.72 | BTK (0.39) | RPS6KA2FABP1KDRSIRT2CHEK2 | |
| SCHEMBL6116264 | 0.70 | BTK (0.51) | KDRSIRT2CHEK2NPC1RAB9A | |
| SCHEMBL13801599 | 0.64 | NPC1 (0.50) | RPS6KA2KDRSIRT2NPC1RAB9A | |
| SCHEMBL7433791 | 0.64 | NPC1 (0.58) | RPS6KA2NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL6115610 | 0.63 | RIPK1 (0.33) | KDR | |
| SCHEMBL5557458 | 0.62 | MEN1 (0.57) | RPS6KA2KDRNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL1416715 | 0.57 | RPS6KA2 (0.47) | RPS6KA2AHRNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL6115598 | 0.56 | BTK (0.58) | FABP1KDRCHEK2 | |
| SCHEMBL4352826 | 0.56 | TOP1 (0.55) | RPS6KA2AHRNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL9269321 | 0.56 | GRIK1 (0.56) | AHRNPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2789614-A1 | Azaindazoles as Btk kinase modulators and use thereof | Bristol-Myers Squibb Company (US) | 2014-10-15 | — | — | EP | disclosed |